Global Information
회사소개 | 문의 | 비교리스트

세계의 면역억제제 API(원료의약품) 시장 예측과 기회(2025년)

Global Immunosuppressants API Market By Method, By Application, By Type, By Product, By APIs, By End User, By Region, Competition, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 934751
페이지 정보 영문 111 Pages
가격
US $ 4,450 ₩ 5,101,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,248,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,834,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 면역억제제 API(원료의약품) 시장 예측과 기회(2025년) Global Immunosuppressants API Market By Method, By Application, By Type, By Product, By APIs, By End User, By Region, Competition, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 111 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 면역억제제 API(원료의약품) 시장은 주로 재생의료(조직공학)의 지속적 기술 진보에 의해 예측 기간 중 압도적인 속도로 성장할 것으로 예상되고 있습니다. 또한 다발성 경화증, 원형 탈모증, 관절염 등 자가면역질환의 발생률 급증이 시장의 성장에 플러스 영향을 미치고 있습니다. 또한 전 세계의 간이식 및 신장이식 등 장기 이식의 증가에 의해 향후 수년간 시장의 성장이 한층 더 가속할 것으로 예상되고 있습니다. 그러나 향후 수년간 세계 면역억제제 API 시장의 성장을 저해하는 주요 요인에는 API에 관련된 고비용과 장기 기증자의 가용성 결여가 포함됩니다.

세계의 면역억제제 API(Immunosuppressants API) 시장은 방법별, 용도별, 유형별, 제품별, API별, 최종사용자별, 지역별로 세분화됩니다. 제품별로 시장은 정제, 캡슐, 액체, 주사로 분류할 수 있습니다. 이 중 정제 부문이 시장을 지배하고 있으며, 주로 비용 효과가 높은 제조 프로세스와 함께 보다 긴 보존 기간으로 인해 예측 기간 중 주도적인 지위를 유지할 것으로 예상됩니다. 또한 정제는 캡슐에 비해 보다 높은 용량의 유효 성분을 수용할 수 있어 향후 수년간 부문의 성장을 지원할 것으로 한층 더 기대됩니다.

세계의 면역억제제 API(원료의약품) 시장에 대해 조사분석했으며, 시장 규모·점유율·예측, 부문별 분석, 경쟁 분석, 시장 동향의 변화, 신규 기회에 관한 정보를 정리하여 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 세계의 면역억제제 API 시장에 대한 COVID-19의 영향

제4장 개요

제5장 고객의 소리

제6장 세계의 면역억제제 API 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 제품 시장 지도

제7장 아시아태평양의 면역억제제 API 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 아시아태평양 : 국가별 분석

제8장 유럽의 면역억제제 API 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 유럽 : 국가별 분석

제9장 북미의 면역억제제 API 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 북미 : 국가별 분석

제10장 남미의 면역억제제 API 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 남미 : 국가별 분석

제11장 중동·아프리카의 면역억제제 API 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 중동·아프리카 : 국가별 분석

제12장 시장 역학

  • 촉진요인
  • 과제

제13장 시장 동향과 개발

제14장 특허 분석

제15장 경쟁 구도

제16장 전략적 제안

KSA 20.05.27

Global immunosuppressants API market is expected to grow at a formidable rate during the forecast period predominantly on account of continuous technological advancements in tissue engineering. Moreover, surging incidence of autoimmune disorders such as multiple sclerosis, alopecia areata and arthritis is positively impacting the growth of market. Also, increase in organ transplants such as liver & kidney transplants worldwide are further expected to bolster the growth of market over the next few years. However, certain factors that can act as major impediments to the growth of global immunosuppressants API market in the forthcoming years include high costs associated with API and lack of availability of organ donors.

The global immunosuppressants API market is segmented based on method, application, type, product, APIs, end user, and region. Based on product, the market can be categorized into tablets, capsules, liquids and injections; out of which, the tablet segment dominated the market and is expected to maintain its leading position during the forecast period as well, majorly on account of their longer shelf life coupled with cost-effective manufacturing process. Additionally, they can accommodate a higher dose of active ingredient as compared to capsules, which is further expected to boost the segmental growth over the coming years. In terms of application, the market is fragmented into autoimmune disease and organ transplant. The autoimmune disease segment held the largest market share until 2019 and is forecast to register higher growth during the forecast period, which is attributable to growing prevalence of autoimmune diseases across the globe. Based on end user, the market is categorized into biotechnology & biopharmaceutical companies, CMOs, CROs, CDMOs, and Others. Among them, the biotechnology & biopharmaceutical companies segment is projected to dominate the market over the next five years, on account of rising investments for research and developmental activities.

Major players operating in the global immunosuppressants API market include Biocon Ltd., NATCO Pharma Limited, Triveni Interchem Private Limited, Concord Biotech Ltd., RPG Life Sciences Limited, Jiangsu Jiuyang Bio-Pharmaceutical Co. Ltd, Chunghwa Chemical Synthesis & Biotech Co. Ltd., AbbVie Inc., Pfizer Inc., Zhejiang Hisun Pharmaceutical Co. Ltd. among others. Leading market players are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, collaborations, partnership, and agreements to increase customer base and expand geographic reach.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and estimate the market size of global immunosuppressants API market from 2015 to 2018.
  • To estimate and forecast the market size of global immunosuppressants API market from 2019 to 2025.
  • To classify and forecast global immunosuppressants API market based on method, application, type, product, APIs, end user, and regional distribution.
  • To identify dominant region or segment in the global immunosuppressants API market.
  • To identify drivers and challenges for global immunosuppressants API market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global immunosuppressants API market.
  • To conduct pricing analysis for global immunosuppressants API market.
  • To identify and analyze the profile of leading players operating in global immunosuppressants API market.
  • to identify key sustainable strategies adopted by market players in global immunosuppressants API market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the companies and presence of all major players operating across the globe.

TechSci Research calculated the market size of global immunosuppressants API market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Immunosuppressants API companies
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to immunosuppressants API
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, suppliers and partners, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global immunosuppressants API market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • By Method:

Synthetic Chemistry

Peptide chemistry

Fermentation

Chromatographic purification

  • By Application:

Autoimmune Disease

Organ Transplant

  • By Type:

Corticosteroids

Janus kinase inhibitor

Calcineurin inhibitors

mTOR inhibitor

IMDH inhibitor

Biologics

Monoclonal antibodies

  • By Product:

Tablets

Capsules

Liquids

Injections

  • By APIs:

Tacrolimus

Sirolimus

Everolimus

Mycophenolate Mofetil

Mycophenolate Sodium

  • By End User:

Biotechnology & Biopharmaceutical Companies

CMOs

CROs

CDMOs

Others

  • By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global immunosuppressants API market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Immunosuppressants API Market

4. Executive Summary

5. Voice of Customer

6. Global Immunosuppressants API Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Method (Synthetic Chemistry, Peptide chemistry, Fermentation, Chromatographic purification)
    • 6.2.2. By Application (Autoimmune Disease, Organ Transplant)
    • 6.2.3. By Type (Corticosteroids, Janus kinase inhibitor, Calcineurin inhibitors, mTOR inhibitor, IMDH inhibitor, Biologics, Monoclonal antibodies)
    • 6.2.4. By Product (Tablets, Capsules, Liquids, Injections)
    • 6.2.5. By APIs (Tacrolimus, Sirolimus, Everolimus, Mycophenolate Mofetil (MMF), Mycophenolate Sodium (MPA))
    • 6.2.6. By End User (Biotechnology & Biopharmaceutical Companies, CMOs, CROs, CDMOs, Others)
    • 6.2.7. By Company (2019)
    • 6.2.8. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Immunosuppressants API Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Method
    • 7.2.2. By Application
    • 7.2.3. By Type
    • 7.2.4. By Product
    • 7.2.5. By APIs
    • 7.2.6. By End User
    • 7.2.7. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Immunosuppressants API Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Method
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Type
        • 7.3.1.2.4. By Product
        • 7.3.1.2.5. By APIs
        • 7.3.1.2.6. By End User
    • 7.3.2. India Immunosuppressants API Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Method
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Type
        • 7.3.2.2.4. By Product
        • 7.3.2.2.5. By APIs
        • 7.3.2.2.6. By End User
    • 7.3.3. Australia Immunosuppressants API Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Method
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Type
        • 7.3.3.2.4. By Product
        • 7.3.3.2.5. By APIs
        • 7.3.3.2.6. By End User
    • 7.3.4. Japan Immunosuppressants API Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Method
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Type
        • 7.3.4.2.4. By Product
        • 7.3.4.2.5. By APIs
        • 7.3.4.2.6. By End User
    • 7.3.5. South Korea Immunosuppressants API Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Method
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Type
        • 7.3.5.2.4. By Product
        • 7.3.5.2.5. By APIs
        • 7.3.5.2.6. By End User

8. Europe Immunosuppressants API Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Method
    • 8.2.2. By Application
    • 8.2.3. By Type
    • 8.2.4. By Product
    • 8.2.5. By APIs
    • 8.2.6. By End User
    • 8.2.7. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Immunosuppressants API Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Method
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Type
        • 8.3.1.2.4. By Product
        • 8.3.1.2.5. By APIs
        • 8.3.1.2.6. By End User
    • 8.3.2. Germany Immunosuppressants API Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Method
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Type
        • 8.3.2.2.4. By Product
        • 8.3.2.2.5. By APIs
        • 8.3.2.2.6. By End User
    • 8.3.3. United Kingdom Immunosuppressants API Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Method
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Type
        • 8.3.3.2.4. By Product
        • 8.3.3.2.5. By APIs
        • 8.3.3.2.6. By End User
    • 8.3.4. Italy Immunosuppressants API Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Method
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Type
        • 8.3.4.2.4. By Product
        • 8.3.4.2.5. By APIs
        • 8.3.4.2.6. By End User
    • 8.3.5. Spain Immunosuppressants API Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Method
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Type
        • 8.3.5.2.4. By Product
        • 8.3.5.2.5. By APIs
        • 8.3.5.2.6. By End User

9. North America Immunosuppressants API Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Method
    • 9.2.2. By Application
    • 9.2.3. By Type
    • 9.2.4. By Product
    • 9.2.5. By APIs
    • 9.2.6. By End User
    • 9.2.7. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Immunosuppressants API Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Method
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Type
        • 9.3.1.2.4. By Product
        • 9.3.1.2.5. By APIs
        • 9.3.1.2.6. By End User
    • 9.3.2. Mexico Immunosuppressants API Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Method
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Type
        • 9.3.2.2.4. By Product
        • 9.3.2.2.5. By APIs
        • 9.3.2.2.6. By End User
    • 9.3.3. Canada Immunosuppressants API Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Method
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Type
        • 9.3.3.2.4. By Product
        • 9.3.3.2.5. By APIs
        • 9.3.3.2.6. By End User

10. South America Immunosuppressants API Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Method
    • 10.2.2. By Application
    • 10.2.3. By Type
    • 10.2.4. By Product
    • 10.2.5. By APIs
    • 10.2.6. By End User
    • 10.2.7. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Immunosuppressants API Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Method
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Type
        • 10.3.1.2.4. By Product
        • 10.3.1.2.5. By APIs
        • 10.3.1.2.6. By End User
    • 10.3.2. Argentina Immunosuppressants API Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Method
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Type
        • 10.3.2.2.4. By Product
        • 10.3.2.2.5. By APIs
        • 10.3.2.2.6. By End User
    • 10.3.3. Colombia Immunosuppressants API Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Method
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Type
        • 10.3.3.2.4. By Product
        • 10.3.3.2.5. By APIs
        • 10.3.3.2.6. By End User

11. Middle East and Africa Immunosuppressants API Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product Type
    • 11.2.2. By Source
    • 11.2.3. By Method
    • 11.2.4. By Technology
    • 11.2.5. By Application
    • 11.2.6. By End User
    • 11.2.7. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Immunosuppressants API Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Method
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By Type
        • 11.3.1.2.4. By Product
        • 11.3.1.2.5. By APIs
        • 11.3.1.2.6. By End User
    • 11.3.2. Saudi Arabia Immunosuppressants API Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Method
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By Type
        • 11.3.2.2.4. By Product
        • 11.3.2.2.5. By APIs
        • 11.3.2.2.6. By End User
    • 11.3.3. UAE Immunosuppressants API Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Method
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By Type
        • 11.3.3.2.4. By Product
        • 11.3.3.2.5. By APIs
        • 11.3.3.2.6. By End User
    • 11.3.4. Kuwait Immunosuppressants API Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Method
        • 11.3.4.2.2. By Application
        • 11.3.4.2.3. By Type
        • 11.3.4.2.4. By Product
        • 11.3.4.2.5. By APIs
        • 11.3.4.2.6. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Competitive Landscape

  • 15.1. Competition Outlook
  • 15.2. Players Profiled (Leading Companies)
    • 15.2.1. Biocon Ltd.
    • 15.2.2. NATCO Pharma Limited
    • 15.2.3. Triveni Interchem Private Limited
    • 15.2.4. Concord Biotech Ltd.
    • 15.2.5. RPG Life Sciences Limited
    • 15.2.6. Jiangsu Jiuyang Bio-Pharmaceutical Co. Ltd
    • 15.2.7. Chunghwa Chemical Synthesis & Biotech Co. Ltd.
    • 15.2.8. AbbVie Inc.
    • 15.2.9. Pfizer Inc.
    • 15.2.10. Zhejiang Hisun Pharmaceutical Co Ltd

16. Strategic Recommendations

Back to Top
전화 문의
F A Q